Why does null hypothesis testing matter for CAM tumor validation?

Null hypothesis testing in the CAM model enables objective evaluation of tumor growth and invasion, supporting robust target validation decisions. This statistical rigor reduces false positives and increases confidence in early oncology findings. Reliable hypothesis testing informs portfolio triage and downstream investment.

How does independent variable isolation fit CAM-based discovery?

Isolating variables such as tumor cell type or treatment in the CAM system allows precise attribution of observed effects to specific interventions. This clarity supports mechanistic de-risking and informs early-stage go/no-go decisions in oncology pipelines. Controlled variable manipulation enhances reproducibility and translational relevance.

What do quantitative dependent variable measurements enable in CAM assays?

Quantitative measurements of tumor size, invasion, or histological features in CAM assays provide actionable data for comparing experimental groups. These outputs enable statistical analysis, benchmarking, and prioritization of candidate interventions. Quantitative endpoints support data-driven advancement in discovery workflows.

Why are replication requirements critical for CAM-based cross-functional studies?

Replication ensures that CAM assay results are robust and reproducible across teams and experiments, facilitating cross-functional collaboration. Consistent replication builds confidence in findings and supports enterprise-wide decision-making. Standardized replication protocols reduce variability and enhance portfolio reliability.

What statistical analysis capabilities are needed before CAM assay implementation?

Effective CAM assay deployment requires statistical tools for hypothesis testing, group comparison, and variance analysis. These capabilities ensure that observed differences are meaningful and support rigorous target validation. Statistical readiness underpins reliable data interpretation and portfolio advancement.

Chick Chorioallantoic Membrane Harvest: A Method to Isolate Tumor Graft-bearing Chorioallantoic Membrane from Chicken Egg

JoVE Encyclopedia of Experiments

Cancer Research

0 views • 2:24 min • April 30th, 2023

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The chorioallantoic membrane or CAM is an extraembryonic membrane, adhering closely to the inner shell membrane of an intact egg. CAM is an ideal system for tumor implantation and modeling because it is a naturally immunodeficient and highly vascularized membrane.

To harvest a tumor-bearing CAM, first, take a viable fertilized chicken egg having a fully developed CAM previously transplanted with a tumor. Add paraformaldehyde to the CAM. Paraformaldehyde crosslinks the membrane proteins, making the membrane stiffer to facilitate its harvesting.

Next, cut around the egg to separate the upper portion of the eggshell from the remainder of the egg, with the tumor-bearing CAM still attached to the removed shell. Hold and lift the CAM at one edge to smoothly detach it from the eggshell.

Thereafter, place the harvested CAM in paraformaldehyde with the tumor graft facing upwards. Paraformaldehyde preserves the morphology of the CAM and tumor graft, thereby preparing the harvested membrane for various downstream analyses.

At the end of the incubation, place the eggs onto the laboratory benchtop. Use a syringe to perforate the film dressing of each egg and apply about 300 microliters of 4% paraformaldehyde over each chorioallantoic membrane to slightly stiffen the tissue to facilitate the harvesting process.

Using scissors, remove the upper half of the eggshell with the chorioallantoic membrane attached. Reduce the size of the shell to approximately 3 centimeters in diameter, keeping the portion of the chorioallantoic membrane where dorsal root ganglion and tumor cells were grafted within the center of the shell fragment. Then, grasp the chorioallantoic membrane with fine forceps and detach the tissue from the eggshell for transfer into one well of a 6-well plate containing 2 milliliters of 4% paraformaldehyde per well.